FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 42 filers reported holding FLEXION THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $974,000 | +19.7% | 40,280 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $814,000 | -6.2% | 40,280 | +24.9% | 0.00% | 0.0% |
| Q1 2017 | $868,000 | +38.9% | 32,254 | -1.8% | 0.00% | 0.0% |
| Q4 2016 | $625,000 | -3.3% | 32,854 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $646,000 | +48.5% | 33,035 | +13.5% | 0.00% | +50.0% |
| Q2 2016 | $435,000 | +85.9% | 29,095 | +14.4% | 0.00% | +100.0% |
| Q1 2016 | $234,000 | -51.2% | 25,435 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $480,000 | +29.7% | 24,928 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $370,000 | +27.6% | 24,928 | +88.2% | 0.00% | +100.0% |
| Q2 2015 | $290,000 | +187.1% | 13,248 | +196.3% | 0.00% | – |
| Q1 2015 | $101,000 | +16.1% | 4,471 | +4.1% | 0.00% | – |
| Q4 2014 | $87,000 | +33.8% | 4,296 | +20.8% | 0.00% | – |
| Q3 2014 | $65,000 | -50.8% | 3,556 | -63.6% | 0.00% | -100.0% |
| Q2 2014 | $132,000 | -59.3% | 9,756 | -50.4% | 0.00% | 0.0% |
| Q1 2014 | $324,000 | – | 19,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clearline Capital LP | 391,076 | $7,317,000 | 4.33% |
| Rubric Capital Management LP | 2,125,000 | $39,759,000 | 4.20% |
| Gagnon Advisors, LLC | 225,062 | $4,211,000 | 2.52% |
| GAGNON SECURITIES LLC | 450,655 | $8,432,000 | 1.94% |
| MILLER VALUE PARTNERS, LLC | 2,881,200 | $53,907,000 | 1.74% |
| PECONIC PARTNERS LLC | 222,965 | $4,172,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 415,000 | $7,765,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 532,812 | $9,969,000 | 1.00% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 574,483 | $10,749,000 | 0.75% |
| Kerrisdale Advisers, LLC | 37,145 | $695,000 | 0.68% |